Oxaliplatin-Induced Immune Thrombocytopenia: Another Cumulative Dose-Dependent Side Effect?
- 1 October 2009
- journal article
- case report
- Published by Elsevier BV in Clinical Colorectal Cancer
- Vol. 8 (4), 220-224
- https://doi.org/10.3816/ccc.2009.n.037
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Drug-Induced Immune ThrombocytopeniaNew England Journal of Medicine, 2007
- Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case reportAnti-Cancer Drugs, 2007
- Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastasesBritish Journal of Surgery, 2007
- Hypersensitivity reactions associated with oxaliplatinExpert Opinion on Drug Safety, 2006
- Patients with quinine-induced immune thrombocytopenia have both “drug-dependent” and “drug-specific” antibodiesBlood, 2006
- Oxaliplatin-related neurotoxicity: How and why?Critical Reviews in Oncology/Hematology, 2006
- Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatinAmerican Journal of Hematology, 2006
- Oxaliplatin‐induced immune pancytopeniaTransfusion, 2005
- Oxaliplatin-Induced Acute-Onset Thrombocytopenia, Hemorrhage and HemolysisOncology, 2004
- Detection of drug‐dependent, platelet‐reactive antibodies by antigen‐ capture ELISA and flow cytometryTransfusion, 1990